We showed previously that 60 days after the induction of Parkinson's disease (PD) in a rat model, there are decreases in baseline breathing and in the number of phox2b-expressing neurons of the retrotrapezoid nucleus (RTN) and nucleus of the solitary tract (NTS), as well as a reduction in the density of the neurokinin-1 receptor (NK1r) in the pre-Bötzinger complex (preBötC) and rostral ventrolateral respiratory group (rVRG). Here, our aim was to evaluate the correlation between neuroanatomical and functional respiratory changes in an experimental model of PD. Male Wistar rats with bilateral injections of 6-hydroxydopamine (6-OHDA, 24 g l −1 ) or vehicle into the striatum had respiratory parameters assessed by whole-body plethysmography 1 day before and 30, 40 or 60 days after the ablation. From the 30th day after the ablation, we observed a reduction in the number of phox2b neurons in the RTN and NTS and a reduction in the density of astrocytes in the rVRG. At 40 days after the ablation, we observed decreases in the density of NK1r in the preBötC and rVRG and of astrocytes in the RTN region. At 60 days, we observed a reduction in the density of astrocytes in the NTS and preBötC regions. The functional data showed changes in the resting and hypercapnia-induced respiratory rates and tidal volume from days 40-60 after injury. Our data suggest that the neuroanatomical changes impair respiratory activity and are presumably a major cause of the respiratory problems observed in PD.
INTRODUCTION
Parkinson's disease (PD) is the most prevalent movement disorder, and the estimation is that the diagnosis of patients with PD will increase from 4 million people in 2005 to approximately 9 million in 2030 (Dorsey et al., 2007; Lee & Gilbert, 2016) . The pathophysiology of PD is associated with a decrease in ventrolateral dopaminergic neurons of the substantia nigra pars compacta (SNc) in the midbrain, which affects the neuronal circuitry that modifies movement control (Spillantini et al., 1998) .
For that reason, since its first description by James Parkinson in 1817 (Blum et al., 2001; Parkinson, 2002) , PD has been primarily associated with motor impairment, with progressive symptoms of rest tremor, rigidity of movement, bradykinesia, akinesia and postural instability (Agid, 1991) . However, it also presents non-motor c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society symptoms, such as breathing disorders that have a negative impact on the quality of life of those individuals. Respiratory problems may be responsible for much of the mortality and morbidity associated with PD (Mehanna & Jankovic, 2010) . However, clinically, respiratory changes remain associated only with the peripheral impairment of motor ventilatory control (Gilman et al., 2003; Solomon & Hixon, 1993; Tzelepis, McCool, Friedman, & Hoppin, 1988) , and data related to central respiratory changes associated with the disease are still lacking in the literature. nucleus (RTN) and the nucleus of the solitary tract (NTS), as well as in the substance P receptor density in the pre-Bötzinger complex (preBötC) and rostral ventrolateral respiratory group (rVRG) (Tuppy et al., 2015) . However, the degeneration of other neuronal structures that integrate the neural circuitry after the evolution of neuropathies of PD can also compromise respiratory function.
Astrocytes located within the RTN region can be modulators of respiratory activity (Gourine et al., 2010; Wenker, Sobrinho, Takakura, Moreira, & Mulkey, 2012 , Sobrinho et al., 2014 . In PD, in addition to the changes in the nigrostriatal pathway, progressive impairment in central structures that control breathing, such as neurons and astrocytes located in the brainstem, may be associated with the onset of respiratory disorders related to the disease. Here, we used an experimental model of PD induced by injecting 6-hydroxydopamine (6-OHDA) into the striatum and evaluated the ventilatory and neuroanatomical changes. Based on the information described above, we asked the following questions: (i) Do the neuroanatomical changes occur before or after the functional changes? (ii) Are there astrocytic changes in the brainstem? (iii) Is there a significant correlation between neuroanatomical changes and breathing leading to impaired homeostasis?
MATERIALS AND METHODS

Ethical approval
All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Animal Experimentation Ethics Committee of the Institute of Biomedical Sciences, University of São Paulo (protocol no. 104/23/03). All experimental protocols presented here were carried out in accordance with the standards and animal ethics principles recognized by the journal and followed the journal's checklist Grundy (2015) .
Animals
The experiments were performed by using 47 male Wistar rats weighing 250-300 g on the day of the surgery. The animals were distributed into different groups according to the time after the induction of the experimental model: 19 control animals (injected with vehicle) and 28 PD animals (30 days: 10; 40 days: 10; and 60 days: 8 animals). The animals had free access to water and food and were housed in a temperature-controlled chamber at 24 • C with a 12:12 h light/dark cycle. All experimental and surgical procedures conformed to the guidelines of the National Institutes of Health and were approved by the Institutional Animal Care and Use Committee at the University of São Paulo.
Experimental model
The induction of the PD model was performed by bilateral injection of 6-OHDA hydrochloride (H4381, Sigma-Aldrich, St Louis, MO, USA, 24 g l −1 ) or vehicle (1 g ascorbic acid in 1 l of saline) in the caudate- putamen region (CPu), while the rats were anaesthetized intraperitoneally (I.P.) with ketamine (Davol, São Paulo, Brazil; 100 mg kg −1 ) and xylazine (7 mg kg −1 ). The rats were placed in a stereotaxic frame (model 1760, David Kopf Instruments, Tujunga, CA, USA), and 6-OHDA (0.5 l/injection) was injected into the CPu at two locations on each side of the brain, at the following coordinates: (i) AP: 0 mm from bregma, ±2.7 mm lateral from midline, 4.5 mm below the skull surface; and (ii) 0.5 mm rostral from bregma, ±3.2 mm lateral from midline, 4.5 mm below the skull surface. The injections were made using pipettes with an external tip coupled to a Hamilton syringe (10 l).
After all surgery, the rats were treated with the antibiotic ampicillin (100 mg kg −1 intramuscularly) and the analgesic ketorolac (0.6 mg kg −1 subcutaneously). For killing, after the functional experiments, the animals were deeply anaesthetized with sodium pentobarbital (60 mg kg −1 I.P.) and immediately perfusion-fixed, following the guidelines of the National Institutes of Health.
Measurements of pulmonary ventilation
Measurements of the ventilatory parameters were performed using the whole-body plethysmography method as previously described (EMKA Technologies, Falls Church, VA, USA) (Oliveira, Tuppy, Moreira, & Takakura, 2017) . Freely moving rats were kept in a 5 litre plethysmography chamber with room air for 45-60 min before the ventilatory parameters were recorded. The plethysmography chamber was continuously operated at a set temperature with humidified inflow gas (23-25 • C ambient room temperature, 60-70% relative humidity, ±0.5 • C; ±5% relative humidity). The chamber was also continuously flushed at 1.5 l min −1 , as regulated by computer-driven mass flow controllers for O 2 , N 2 and CO 2 (Alicat Scientific, Inc., Tucson, AZ, USA).
The flow controllers were adjusted to 21% O 2 balanced with N 2 in normoxia and to 7% CO 2 , 21% O 2 and 72% N 2 in hypercapnia. The hypercapnia protocol was performed for 10 min.
Rectal temperature was used as a core body temperature index and was measured twice: before and at the end of the experiments. The calibration for volume was obtained by waveforms generated during each experiment by injecting the animal chamber with 20 ml of dry air, as calculated using Spike2 software version 7.3 (Cambridge Electronic Design, Cambridge, UK). The ventilatory parameters measured by the plethysmography system were tidal volume (V T , ml (kg body weight) −1 ; area under the curve during the inspiratory period) and respiratory frequency (f R , breaths min −1 ). Ventilation (V E , ml min −1 (kg body weight) −1 ) was calculated as the product of f R and V T . The measurements were performed 30, 40 or 60 days after vehicle or 6-OHDA injection into the CPu.
Immunohistochemistry
At the end of the experiments, the animals were deeply anaesthetized with sodium pentobarbital (60 mg kg −1 , I.P.) and perfused through the ascending aorta with 350 ml of heparinized saline (pH 7.4) followed by 500 ml of 4% phosphate-buffered paraformaldehyde (PFA, pH 7.4).
Brains were removed and post-fixed in PFA for 1-2 days at 4 • C.
Series of coronal sections (40 m) from the brain were cut using a microtome (Leica SM2010 R, Cincinnati, OH, USA) and stored in cryoprotectant solution at −20 • C (20% glycerol plus 30% ethylene glycol in 50 ml phosphate buffer, pH 7.4) for up 2 weeks until histological processing (Schreihofer & Guyenet, 1997) . All histological procedures were performed with free-floating sections. No labelling was observed when the primary antibodies were omitted.
Sections were rinsed, blocked and stained via the immunoperoxidase method with antibody specific for detection of tyrosine hydroxylase (mouse anti-TH, MAB 318, Millipore, Billerica, MA, USA, dilution 1:1000), the transcription factor phox2b (rabbit anti-phox2b, gift from J.-F. Brunet, Ecole Normale Supèrieure, Paris, France, dilution 1:800), glial fibrillary acidic protein (GFAP) (mouse anti-GFAP, AB5804, Millipore, dilution 1:5000), and neurokinin-1 receptor (NK1r) (rabbit anti-NK1r, Sigma-Aldrich, 1:7500) as previously described (Barna, Takakura, & Moreira, 2012) . All the sections were incubated in chromogen 3,3 ′ -diaminobenzidine solution for 10 min and were mounted on gelatinized slides in a rostrocaudal sequence and subsequently dehydrated in alcohol and covered with DPX mountant (Sigma-Aldrich).
Neuroanatomical analysis, image acquisition and cell counting
A multifunction microscope (Nikon Eclipse E-1000, Melville, NY, USA) coupled to a digital camera (Nikon DXM-1200) was used to image sections and to perform subsequent analysis (Silva, Tanabe, Moreira, & Takakura, 2016; Takakura, Barna, Cruz, Colombari, & Moreira, 2014) . Section alignment between brains was completed relative to a reference section, as previously described (Tuppy et al., 2015) . Briefly, to align sections around the SNc level, the most caudal section containing the medial geniculate nucleus was identified in each brain and assigned the level 6.04 mm caudal to bregma (distance from bregma = −6.04 mm). To align sections around the NTS, the most caudal section that contained the fourth ventricle was identified in each brain and assigned the level of 13.68 mm caudal to bregma (distance from bregma = −13.68 mm). To align sections around the RTN, the most caudal section that contained an identifiable cluster of facial motor neurons was identified in each brain and assigned the level of 11.6 mm caudal to bregma (bregma = −11.6 mm). To align sections around the preBötC and rVRG, the most caudal section that contained the linear nucleus was identified in each brain and was assigned the level of 12.30 mm caudal to bregma (distance from bregma = −12.30 mm). Levels rostral or caudal to these reference sections were determined by adding a distance corresponding to the For densitometric analysis of NK1r and GFAP immunoreactivity, the area of interest was outlined using landmarks, as follows. preBötC and rVRG: the areas were defined by a circle with a radius of 850 m, the top centred on the ventral edge of the nucleus ambiguus or retroambiguus (Totola, Takakura, Oliveira, Garcia-Cairasco, & Moreira, 2017) . RTN region: the area was defined by outlining from halfway down the medial edge of the facial motor nucleus around the lateral of the ventral edge of this nucleus and then perpendicular to the ventral surface. The region continued medially along the ventral surface to the medial edge of the pyramidal tract and closed with a diagonal to the medial edge of the facial nucleus. NTS, area postrema and DMV regions: the areas were defined by outlining the identifiable tissue as defined by Paxinos & Watson (1998) . The area of pixels containing segments was calculated by the software, and the data are shown as a percentage of control, with the control value defined as 100%.
Statistical analysis
Statistical analysis was performed using the program SigmaStat 3.0 (Systat Software, San Jose, CA, USA). Additionally, the cycle duration of each respiratory event (T TOT ) and its variability were analysed.
Poincaré analysis was applied for breathing variability, where the duration of each breath taken during normocapnia (120 breaths) was plotted against the duration of the next breath. We then calculated the width of the variation perpendicular to (SD1) and along the line of identity (SD2) One-way repeated-measures ANOVA was followed by Bonferroni (functional analysis) or Tukey (neuroanatomical analysis) post hoc tests, as indicated. Student's t test was used in GFAP expression analyses. To evaluate the correlation between the degree of lesioning of the brain regions and the functional changes, we used the Pearson correlation (r). The level of significance was set at P < 0.05.
RESULTS
Temporal neuroanatomical changes produced by 6-OHDA injection into CPu
Neuroanatomical analysis was performed in the SNc to characterize the model of PD. The results showed that at 30 days after 6-OHDA injection into the CPu, there was a reduction of more than 70% in the number of TH-immunoreactive (ir) neurons (30 days, 399 ± 13; 40 days, 406 ± 58; and 60 days, 336 ± 76; vs. vehicle, 1505 ± 186 neurons; P < 0.001; Figure 1 ).
We also analysed the respiratory regions and noticed that for phox2b-expressing neurons of the RTN and NTS, similarly, at 30 days after 6-OHDA injection, there was a significant reduction in the neuro- NK1r-ir density was analysed in the preBötC and rVRG. The results showed that in both regions, there was a reduction in the density of NK1r-ir since 40 days after 6-OHDA injection in CPu (preBötC: 40 days, 7.4 ± 3%; 60 days, 4 ± 1%; vs. vehicle, 16.4 ± 7%; P < 0.05; Figure 5a ,c,e,g,i; rVRG: 40 days, 5.5 ± 1.9%; 60 days, 4.4 ± 1.35%; vs.
vehicle, 11.4 ± 4.15%; P < 0.001; Figure 5b ,d,f,h,i).
Because astrocytes can also be involved in respiratory control (Gourine et al., 2010) , we decided to analyse changes in the GFAP density in the respiratory regions. The results showed that at 30 days after 6-OHDA injection, there was a reduction in the GFAP-ir density in the rVRG (10 ± 2.4% vs. vehicle, 19.25 ± 5%; P < 0.05; Figure 7b ,d,e); at 40 days, there was a reduction in GFAP-ir density in the rVRG and RTN (rVRG: 12.3 ± 4%, vs. vehicle, 19.25 ± 5%; RTN: 6 ± 6%, vs.
vehicle, 23.7 ± 14%; P < 0.05; Figures 6a,b,g and 7b,d,e); and at 60 days, all the regions analysed showed decreased GFAP-ir density (rVRG: 10 ± 3.7, vs. vehicle, 19.25 ± 5%; RTN: 5.4 ± 3.7, vs. vehicle, 23.7 ± 14%; NTSc: 17.3 ± 4%, vs. vehicle, 32.7 ± 7.3%; P < 0.05; NTSi: 24.5 ± 4%, vs. vehicle, 36.3 ± 7%; P < 0.05; preBötC: 7.7 ± 3.9, vs. vehicle, 15.5 ± 5.4%; P < 0.05; Figures 6 and 7) . We also performed GFAPir analysis (at 60 days) on brainstem regions that are not involved in breathing such as area postrema and DMV. The results showed (e) Number of neurons immunoreactive for tyrosine hydroxylase (TH-ir) in the SNc. One-way ANOVA followed by Tukey's post hoc test. Data displayed as mean ± SD. (*P ≤ 0.001, different from vehicle). The scale bar in (d) applies to (a-d). SNC, substantia nigra, compact part; SNR, substantia nigra, reticular part; VTA, ventral tegmental area that there was a reduction in the GFAP-ir density only in DMV (area postrema: 6.2 ± 5.9%, vs. vehicle, 6.8 ± 4.5%; P > 0.05; and DMV: 8.2 ± 0.9 vs. vehicle, 27.3 ± 8.8%; P < 0.05; Figure 6c-g ).
Temporal respiratory functional changes produced by 6-OHDA injection into CPu
In the same group of animals, we also performed functional experiments in order to record resting breathing and the hypercapnic ventilatory response (HCVR). As already demonstrated, the resting f R (40 days, 88 ± 5 breaths min −1 ; and 60 days, 81 ± 6 breaths min −1 ; vs. vehicle, 113 ± 6 breaths min −1 ; P < 0.001) andV E (40 days, 643 ± 58 ml kg −1 min −1 ; and 60 days, 377 ± 51 ml kg −1 min −1 ; vs.
vehicle, 877 ± 127 ml kg −1 min −1 ; P < 0.05) began to decrease 40 days (Figure 8a,c) . Only at 60 days after 6-OHDA was the reduction in resting tidal volume (V T ) (3.2 ± 0.5 vs. vehicle 4.9 ± 1.9 ml kg −1 ; P < 0.05) considered significant (Figure 8b ).
Because some of the respiratory regions analysed are also involved in central chemoreception, we tested the ability of animals to respond to a hypercapnic (7% CO 2 ) stimulus. The results showed changes in the increases in f R andV E at 40 and 60 days after bilateral injections of 6-OHDA into the CPu (f R : 40 days, 115 ± 7 and 60 days, 120 ± 7, vs. vehicle 131 ± 4 breaths min −1 ; andV E : 40 days: 1138 ± 192 and 60 days, 701 ± 161, vs. vehicle 1414 ± 270 ml kg −1 min −1 ; P < 0.05; Figure 8d ,f). Only 60 days after injection of 6-OHDA in CPu, a change in the increase in V T produced by hypercapnia was observed (4.6 ± 1, vs. vehicle 10.3 ± 2.7 ml kg −1 ; P < 0.05; Figure 8e ). The hypercapnic response was also analysed by assessment of delta change from baseline. The results showed that only at 60 days after bilateral injections of 6-OHDA into the CPu there was an increase in the f R (38.7 ± 8.3, vs. vehicle 27.6 ± 11.8 breaths min −1 ; P < 0.05) and a decrease in V T (1.4 ± 0.5, vs. vehicle 5.3 ± 2.7 ml kg −1 ; P < 0.05) that led to no significant changes inV E (324 ± 146, vs. vehicle 537 ± 290 ml kg −1 min −1 ; P > 0.05) (Figure 8g-i) .
With regard to breathing variability, we evaluated the values for cycle duration (T TOT ) variability during normocapnia (21% O 2 ) for control (vehicle) and lesioned (6-OHDA) animals. We observed that, after bilateral injection of 6-OHDA, in addition to the reduction of f R ,
there was an increase in T TOT variability (6-OHDA: 0.739 ± 0.08 ms vs. vehicle: 0.683 ± 0.05 ms; P < 0.001, one-way ANOVA). The SD1
and SD2 parameters were used to quantify the distribution of the points. No significant difference was observed for the SD1 parameters 
Correlation between neuroanatomical and functional respiratory changes produced by 6-OHDA injection into the CPu
The regions analysed in the present study are involved in breathing control. For this reason, the following experiment was performed Finally, we also performed a correlation analysis between hypercapnia-induced respiratory and neuroanatomical changes.
The results showed that for all regions analysed, there was a strong and significant correlation between the reduction in the number of phox2b-expressing neurons (f R : r = 0.471, P = 0.04) in the region of RTN and the change in f R induced by hypercapnia (Figure 9e ).
DISCUSSION
The present study showed that in a 6-OHDA model of PD, neuro- The HCVR was not changed due to an increase in breathing rate and a decrease in V T during hypercapnia after induction of the PD model. Interestingly, we also described for the first time an increase in the variability of respiratory frequency during normocapnia of PD animals. A significant positive correlation between neuroanatomical and functional changes supports the idea that respiratory deficits are related to changes in the cytoarchitecture of the brainstem regions involved in breathing activity.
Breathing control in Parkinson's disease
We confirm data from the literature that a significant loss of neuronal profiles in brainstem regions involved in breathing control dramatically affect breathing output (Feldman & Ellenberger 1988; Feldman, Del Negro, & Gray, 2013; Guyenet & Bayliss, 2015; Oliveira et al., 2017; Richter, 1982; Richter, 2001; Smith, Abdala, Koizumi, Rybak, & Paton, 2007; Tuppy et al., 2015) .
Within the NTS region, there is a group of neurons that harbour the dorsal respiratory column and also express the transcription factor phox2b and presumably contribute to the regulation of breathing and autonomic regulation (Kang et al., 2007; Stornetta et al., 2006) . , for 120 breaths, during resting conditions for animals that received vehicle (j) or 6-OHDA (24 g l −1 ; k). Under resting conditions, ANOVA with repeated measures and general linear model (GLM) and Bonferroni post hoc tests were used. Under hypercapnia (7% CO 2 ), one-way ANOVA followed by Tukey's post hoc test was used. Data displayed as mean ± SD (*P < 0.05, different from vehicle)
In addition, pharmacological blockade of the NTS attenuates the ventilatory and cardiovascular responses to chemoreceptor activation (Berger & Cooney, 1982; Favero et al., 2011; Nattie & Li, 2008) . All data described above are related to physiological conditions; however, in the present study, we verified that in a model of PD, there was a reduction in the number of phox2b-expressing neurons in the NTS region that could be correlated with the loss of autonomic and respiratory function (Falquetto et al., 2017; Oliveira et al., 2017; Tuppy et al., 2015) . For example, we showed before that disruption of phox2b-expressing neurons in the NTS impacts the proper function of cardiovascular reflexes (Falquetto et al., 2017) . A significant number of PD patients have orthostatic hypotension, suggesting a cardiovascular dysautonomia (Goldstein, 2003) . One of the pathophysiological mechanisms underlying the cardiovascular autonomic abnormalities of PD is arterial baroreflex failure due to decreased function of both the parasympathetic and sympathetic components. Medullary neuronal loss may contribute to these autonomic dysfunctions in patients with PD (Benarroch, Schmeichel, & Parisi, 2000) . As for respiratory control, it seems that the ablation of phox2b-expressing neurons in the NTS could be associated with hypoventilation syndromes such as the congenital central hypoventilation syndrome (CCHS) (Fu et al., 2017) .
In the same period, we also observed a reduction in the number of phox2b neurons at the level of the RTN. In the rat, the RTN consists of a column of approximately 2000 phox2b-expressing neurons that are involved in chemoreception and have a modulatory effect on the activity of ventral respiratory neurons (Guyenet & Bayliss, 2015; Kumar et al., 2015; Mulkey et al., 2004; Takakura et al., 2008; Takakura et al., 2014) . The respiratory symptoms of CCHS are the absence of HCVR and sleep-related central apnoeas. Impaired HCVR in PD has been closely associated with the structural and functional deficiency of phox2b-expressing neurons, in particular, those neurons serving as central respiratory chemoreceptors within the RTN.
The ventral respiratory group (VRG) consists of four rostrocaudal subregions, all of which receive RTN input. Within the VRG, the preBötC contains a bilateral cluster of glutamatergic bursters (also immunoreactive for NK1r and somatostatin) that operate as a rhythm generator for breathing (Bouvier et al., 2010; Feldman & Kam, 2015; Feldman et al., 2013) . The rostral ventral respiratory group (rVRG) resides more caudally in the VRG and harbours inspiratory premotor neurons (Smith, Abdala, Borgmann, Rybak, & Paton, 2013) . In the present study, we showed a reduction in the density of NK1r in both regions starting 40 days after the induction of the PD model. The decreased NK1r expression in key areas related to breathing activity could certainly justify the loss-of-function phenotype observed in our animal model of PD.
In addition to the loss of several neuronal profiles within the ventral respiratory column (VRC), several recent reports have described a role for astrocytes in breathing and autonomic regulation (Angelova et al., 2015; Gourine et al., 2010; Marina, Kasymov, Ackland, Kasparov, & Gourine, 2016; Sobrinho, Gonçalves, Takakura, Mulkey, & Moreira, 2017; Wenker et al., 2010) . The changes in glial profile are not selective to brainstem respiratory regions in this model. We know that astrocytes in key areas of the brainstem (RTN and preBötC) are unique to the control of chemoreception and breathing automaticity (Gourine et al., 2010; Sobrinho et al., 2014; Wenker et al., 2012) . However, it is important to note that our model consists of a degenerative animal model of PD, in which in our understanding the entire brain will degenerate over time, including the respiratory column, leading to respiratory deficits. Losing astrocytes in key regions involved in breathing activity will produce an ATP deficiency, which in turn will fail to stimulate breathing. This seems to be the mechanism for the RTN and preBötC (Angelova et al., 2015; Sobrinho et al., 2014; Wenker et al., 2012 The underlying mechanisms associated with degeneration of neuronal profiles within the brainstem related to breathing control in experimental models of PD are not known. A recent study from our laboratory showed that apparently there is not a direct projection from midbrain dopaminergic neurons to the RTN region. However, the presence of an indirect pathway that goes through periaqueductal gray matter (PAG) could explain this change, especially because this indirect pathway is also impaired in this model (Lima, Oliveira, Bötelho, Moreira, & Takakura, 2018) . The presence of projections from SNc to other medullary regions involved in breathing should be investigated.
Another possibility is the fact that patients with PD have a clear dysfunctional blood-brain barrier (Kortekaas et al., 2005) . If that is the case in our model, a disruption in the blood-brain barrier in the medulla could lead to death of brainstem neurons, astrocytes and receptors.
Lastly, it was already observed in the SNc region that the presence of mitochondrial dysfunction can be associated with an increase in oxidative stress (Schapira, Mann, & Cooper, 1990; Subramaniam & Chesselet, 2013; Tanaka, Ogawa, & Asanuma, 2006) . In that case, the same mechanism may also be present in the brainstem.
Respiratory disturbances have previously been described in patients with PD as a non-motor symptom that can have a negative impact on patients' quality of life (Martinez-Martin, 2011) . In a study conducted by Seccombe et al. (2011) , it was hypothesized that the respiratory changes observed could be associated with a dysfunction of respiratory neurons of the brainstem. They observed in patients with PD that there was some degree of weakness in the respiratory muscles, but it was insufficient to cause any significant restriction. In addition, there was a 47% deficit in response to hypercapnia, but not to hypoxia, suggesting a change in respiratory control under high levels of CO 2 (Seccombe et al., 2011) . In the present study, it was possible to verify that 30 days after the induction of the experimental model of PD, changes in neuronal cytoarchitecture occurred in crucial regions related to breathing control, such as the VRC and the NTS.
Regarding the functional changes, 40 and 60 days after bilateral injections of 6-OHDA, it was possible to observe markedly reduced baseline breathing and hypercapnia-induced changes in f R and V T . The HCVR was not significantly changed within the time frame of our study; our analysis showed a reduction in V T response and an increase in f R response to hypercapnia leading to no change in theV E response to high CO 2 . Despite the fact that the HCVR was not changed in our 6-OHDA PD model due to a presumably compensatory effect, it is important to point out that breathing instability was present over the course of the disease stage studied in this model. In agreement with the present data, previous studies demonstrated that bilateral lesions of SNc neurons altered the respiratory pattern in conscious rats Tuppy et al., 2015) . The absence of changes in the acidbase equilibrium or in the partial pressure of the arterial gases after the induction of the PD model (Tuppy et al., 2015) suggests that, unless there is a change in the oxygen consumption and body temperature, the animals are ventilating in accordance with their metabolic needs.
Unfortunately, because of technical limitations, we were not able to perform measurements of oxygen consumption, but this needs to be further investigated. Nevertheless, the breathing impairment under resting conditions and at high levels of CO 2 was well correlated with the reduction in VRC neurons, especially the neurons located in the RTN, preBötC and rVRG. We conclude that the neuroanatomical changes occur progressively and begin before the respiratory deficits.
In conclusion, the present study provides the first evidence that 
